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Abstract
When multiple similar protein or peptide chains form non-covalent aggre-
gates, this is termed ‘amyloid’. Many serious progressive diseases such as
Alzheimer’s and Parkinson’s are related to undesirable amyloid aggregation.
From a positive perspective, functional amyloids have applications as robust
and versatile biomaterials in nature, nanotechnology, and biomedicine. To
probe the properties of the amyloid aggregation process in terms of the struc-
ture of molecules and the microscopic interactions between them, molecular
simulation methods such as molecular dynamics (MD) and Monte Carlo (MC)
can be used. These tools are especially valuable to illustrate short length and
time scales not easily accessible for systems in solution via current experimen-
tal techniques.
In this work the thermodynamics and aggregation kinetics of the ILQINS
hexapeptide are studied. ILQINS is a biological material derived from hen’s
egg-white lysozyme. Two ILQINS homologues, IFQINS and TFQINS are
compared to ILQINS and some of the complex physics which leads to the
increased amyloidogenicity of these species, which is not expected from first-
order consideration of amino acid properties, is discussed.
The IFQINS hexapeptide is of particular interest as the human homologue of
ILQINS. Solution X-ray and X-ray crystallography are compared to simula-
tion, verifying that at least two metastable polymorphic structures exist for this
system which are substantially different at the atomistic scale, and illustrating
the physics driving kinetic competition between polymorphs.
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Chapter 1
Introduction
In this introductory chapter the basic concepts of peptide sequence, or ‘primary structure’
are introduced. Peptide local configuration, or ‘secondary structure’ is also introduced with
emphasis on the parallel (P) and antiparallel (AP) β -sheet secondary structures which are a
common signature of amyloid formation. The varying mesoscale morphologies of peptide
aggregates which may have similar primary and secondary structures is motivated. Finally,
the specific lysozyme-derived hexapeptides studied in this thesis and the methods used are
introduced.
1.1 Peptide Structure
Polypeptides are chains of amino acids held together by peptide bonds. A peptide bond
is formed when the carboxyl group of one amino acid binds the amino group of another
amino acid in a condensation reaction and a molecule of water is released [4] (see Figure
1.1).
Figure 1.1: Two amino acids make a dipeptide and a water molecule is released.
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The difference between a peptide and a protein is defined such that all proteins are also
peptides but not all peptides are proteins. Typically we define a peptide as a protein if it has
more than 50 residues (50 amino acids) and is composed of biologically available amino
acids. If a small or non-natural peptide nonetheless has a stable globular fold we may still
call it a protein.
Peptide bonds are rigid, shorter than the C–N bond in a simple amine, and unable to
rotate freely: the atoms associated with the peptide bond are co-planar. The major rotational
degrees of freedom are about the N–Cα and Cα–C bonds, so we can consider the backbone
of a polypeptide chain as a series of rigid planes with consecutive planes sharing a common
point of rotation at Cα as illustrated in Figure 1.2. Rotations about N–Cα and Cα–C bonds
are labeled φ and ψ respectively and are known as torsion or dihedral angles [5].
The values of torsion angles define the backbone conformation of the peptide chain [1,6,
7], however the presence of sidechains (for all amino-acids apart from Glycine) constrains
the allowed backbone torsions. Flexible sidechains will have further degrees of freedom,
and sidechain-sidechain interactions are decisive in determining preferred conformations.
Steric, electrostatic and dispersion interactions between sidechains make determination of
the structure or structural ensemble for a chain or set of chains a complex many-body
optimisation problem. In nature, the sequence of sidechains is selected by evolution to
determine the structure and/or assembly of the protein such that it serves its function (or
often many functions) in the organism.
Although torsion angles can formally have any value between -180◦ and +180◦ many
values are not possible because of steric clashes between atoms in the polypeptide backbone
and side chains. Allowed values for torsion angles vary considerably by sequence, however
a general pattern exists which is graphically shown in the Ramachandran plot [8] of Figure
1.3.
One of the most prominent secondary structures of polypeptides which occurs widely
in folded globular proteins is β conformation where polypeptide chains form sheets [9,10].
The backbone of the chain is extended and the chains are arranged to form (possibly curved)
planar sheets with hydrogen bonds between adjacent strands. Neighbouring β -strands in a
β -sheet can be either parallel (having the same amino-to-carboxyl orientation) or antipar-
allel (having opposite amino-to-carboxyl orientation) (see Figure 1.2). Three-dimensional
protein structure data from the Protein Data Bank (PDB) show that the majority of β -sheets
in folded proteins are antiparallel sheets [11], however this arises mostly from the topolog-
ical constraint that sheets are formed from a continuous peptide chain. Although hydrogen
bonding geometry appears different the free energy of formation for assemblies of inde-
2
pendent chains in P or AP β -sheet is roughly the same [12], with the more stable of the two
being determined by the sidechains.
Figure 1.2: The backbone of polypeptide chains as a series of rigid planes with consecu-
tive planes sharing a common point of rotation at Cα . a Parallel β -sheet conformation of
polypeptide chains. b Antiparallel β -sheet conformation in which the amino-terminal to
carboxyl-terminal orientation of adjacent chains is reversed.
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A currently debated possible structure of particular interest in relation to amyloid for-
mation is α-sheet, which is similar to β -sheet, but with different orientation of the carbonyl
and amino groups in the peptide bond units; in each strand, all the carbonyl groups are
oriented in the same direction on one side, and all the amino groups are oriented in the
same direction on the opposite side [13, 14]. On the Ramachandran plane (Figure 1.3) this
equates to alternating between the α-L and α-R regions to give near-zero net twist. Like
β -sheet, α-sheet may be formed between separate chains, and α-sheet to β -sheet inter-
conversion via peptide plane flipping may be a stage in the assembly of some multichain
aggregates [15]. Further interesting conformations in relation to multichain assembly in-
clude β -sheet curved to form a cylindrical tube structure, called β -barrel, in which the first
strand is bonded to the last strand via hydrogen bonds. β -barrel membrane proteins carry
out various functions in different organisms [16,17], and β -barrel oligomers have also been
advanced as a neurotoxic species [18, 19].
Figure 1.3: Ramachandran plot of the torsional angles in a peptide for various allowed
secondary structures. The torsional angles determine the conformation of the residues and
the peptide. Blue areas show the fully allowed conformations that involve no steric over-
lap; green areas indicate conformations allowed subject to slightly unfavourable atomic
contacts; yellow area reflects conformations with significant strain [1].
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1.2 Peptide aggregation
1.2.1 Amyloids
One of the most important problems in protein chemistry and molecular medicine is to un-
derstand and control the misfolding and aggregation of so-called ‘amyloidogenic’ proteins
which contain sequences that interact strongly with other proteins of the same sequence,
forming intramolecular assemblies which are typically β structured [20–23]. Amyloid
oligomers play a key role in amyloid deposition diseases; many degenerative diseases such
as Alzheimer’s, Parkinson’s, and Huntington’s, are related to undesirable amyloid aggre-
gation [24–26].
Proteins can aggregate in regular assemblies by changing their structure from native
forms to cross-beta-sheets, forming amyloids [27–29]. Although the mechanisms of pro-
tein self-assembly are often complex and still not well understood, experimental studies
suggest that nucleation and growth processes are usually an important part of the aggrega-
tion kinetics [30–34]. Amyloid formation in physiological conditions is typically a process
of nucleated polymerization, which begins slowly with aggregation of monomers to form
oligomeric nuclei, then is accelerated with addition of monomers, formation of fibrils, and
their growth [35–38]. This may include homogenous nucleation in that no foreign surface
is involved, heterogeous nucleation on the surface of some other entity, or secondary nucle-
ation from a parent seed aggregate of the same type [39]. Homogenous primary nucleation
occurs directly from a supersaturated solution and is typically dominant only during the
start up phase of a non-seeded crystallization process, whereas the secondary nucleation
uses crystals present in the solution as a site and source for the formation of nuclei and is
observed at lower supersaturation compared to primary nucleation [40, 41].
Amyloid β (Aβ ) is a small self-assembling peptide that is crucially involved in such
diseases. It can aggregate to form flexible soluble oligomers that are toxic to nerve cells
[26, 42–44]. Small oligomers and protofibrils also have important and strong neurological
activities and targeting these oligomers might play a key role in prevention of amyloid
diseases [45]. Nevertheless, Aβ has a normal biological function in host organisms and
may be non-toxic in its form as mature fibrils [46]. Further natural and designed amyloid-
forming systems which appear to be benevolent or at least non-toxic have applications
as unique biomaterials in nanotechnology and biomedicine [47–51]. The explanation for
some amyloid species being non-toxic seems in many cases to be that they rapidly pass
through the small-oligomer stage, producing mature fibrils which are immobile, insoluble
and inert [52]. This opens the fascinating possibility that therapies for amyloid disease
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might in future include acceleration of the amyloid aggregation process, or use of small-
molecule agents to nudge the assembly into more stable polymorphs which can absorb
more monomers and oligomers from solution.
1.2.2 Noncovalent Interactions
Noncovalent interactions are essential in maintaining the three-dimensional structure of
proteins and nucleic acids. They are also involved in many biological processes in which
large molecules bind specifically but transiently to one another [53]. These interactions
also play a key role in amyloid fibril formation and their stability [54–56]. Noncovalent
interactions range from∼ 60 kcal/mol for ion-ion interactions in vacuum to∼ 0.5 kcal/mol
for dispersion interactions [57]. They can be classified into different categories [58, 59],
such as electrostatic, hydrogen bonding, hydrophobic and van der Waals interactions.
Electrostatic Interaction
Interaction between charges is a well-known type of noncovalent interaction which is usu-
ally employed to induce structural specificity for charged peptides in formation of nanos-
tructures [60, 61]. Electrostatic bonds based on Coulombic attractions between opposite
charges lead to the formation of salt bridges with the strongest interaction energies in the
range of ∼ 50−70 kcal/mol in vacuum [57]. The solvent strongly influences electrostatic
interactions, for example in water the strength of electrostatic interactions are weakened by
about 80-fold [62] (dielectric constant of water is about 80). Minimization of the distance
between two oppositely charged ions will be important in the structure of the supramolec-
ular aggregate, even though there is no particular directionality in the ion-ion interaction.
Interactions between ions and dipoles are weaker (∼ 10−50 kcal/mol) but in this case the
orientation of the dipole with respect to the charge is important [58].
Hydrogen Bonding
Hydrogen bonding plays an important role in molecular self-assembly processes such as
micelle formation, biological membrane structure, fibril formation and the determination
of protein conformation [59, 63]. Hydrogen bonds are weaker than ionic interactions and
occur between a proton donor group, which is the strongly polar group in a molecule
such as F-H, O-H, N-H, S-H, and an slightly electronegative proton acceptor atom such
as fluorine, oxygen, nitrogen and sulfur. Hydrogen bonds have energies in the range
∼ 15−30 kcal/mol (heteroatom-heteroatom distances between 2.2−2.5Å) for strong hy-
drogen bonds, ∼ 3.5− 15 kcal/mol (2.2− 3.2Å) for moderate hydrogen bonds and below
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3.5 kcal/mol (long donor-acceptor distances of up to 4Å) for weak hydrogen bonds. Also,
the range of possible hydrogen bond angles for strong hydrogen bonds is 175◦-180◦, while
it is more flexible for moderate (130◦-180◦) and weak (90◦-150◦) hydrogen bonds [58].
Among different noncovalent interactions, hydrogen bonding is probably the most impor-
tant in peptide self-assembly. Conversion of peptides into diverse one dimensional (1D),
2D, and 3D nanostructures can be induced by the selectivity and high directionality of
hydrogen bonds [64].
Hydrophobic Interactions
Hydrophobic interaction arises from the minimization of surface between polar/protic and
unpolar/aprotic molecules which is energetically more favorable [58]. In addition to charge
interactions between amino acids, their ability to form hydrogen bonds with surrounding
water molecules is an important driving force for the conformation of proteins. In compact
conformation of globular proteins hydrophobic groups are buried in the center to avoid
contact with the surrounding water. Also, hydrophobic parts of amphipathic molecules try
to aggregate to minimize their surface area in contact with water, leaving the hydrophilic
parts exposed to water [64].
Hydrophobic effects are also important in guest binding by cyclodextrins. By replacing
the water molecules residing inside the unpolar cavity with an unpolar guest, their inter-
action with other water molecules outside the cavity will be much stronger, and favorable
for the enthalpy. This is also favorable for entropy because by replacing several water
molecules with one guest the total number of translationally free molecules increases [58].
Van der Waals Interactions
Van der Waals forces are on the weak end of noncovalent interactions with energies about
1 kcal/mol, but the forces act between all types of atom and molecule. These forces arise
from the interaction of an electron cloud polarized by adjacent nuclei. In other word they
are the result of fluctuations of the electron distribution of two closely spaced molecules
and can be treated as a type of instantaneous electrostatic interaction [64].
The effective range of van der Waals forces can reach hundreds of angstroms. They are
attractive dispersion interactions, which decrease with the distance r in a r−6 dependence,
and are counteracted at close range by strong electron-electron repulsion forces. Simi-
lar to the interaction between aliphatic tails in peptide amphiphiles, van der Waals forces
provide an important contribution to various noncovalent interactions and they are ubiqui-
tous in assembly systems. However, because van der Waals forces do not have the same
specificity as electrostatic forces or complex interactions such as hydrogen bonding, only
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a few examples engage van der Waals interactions as a dominant force for the control of
self-assembly [65, 66].
1.2.3 Polymorphism
In order to understand the mechanism of oligomer formation detailed structures of amyloid
oligomers are needed. Amyloids are generally polymorphic at the molecular level, and a
given peptide or protein can form different morphologies [12, 67–70] including filaments
[71], nanotubes [72], helical ribbons [73–75], twisted ribbons [74, 75] and crystals [75,
76]. Amyloid fibrils and crystals formed from the same polypeptide can have different
arrangements of the β -strands and make different symmetry classes [2, 77].
Figure 1.4 shows the eight allowed symmetries to form a two-β -sheet ‘steric zipper’ [2].
The different fibril symmetry classes are illustrated with left hands. The arrangment of β -
strands within each β -sheet is either parallel (classes 1–4) or antiparallel (classes 5–8).
Figure 1.4: Eight different fibril symmetry classes [2] illustrated with left hands. Ra, Rb
and Rc show rotations of 180◦ about a, b and c axis. Classes 1–4 have parallel alignment of
β -strands within each β -sheet and classes 5–8 have antiparallel arrangement of β -strands
within their β -sheets. Each peptide sequence may have the ability to form one or more of
these morphologies.
The selection of symmetry class represents the ‘middle’ level of amyloid polymor-
phism. At the smaller level, amyloid assemblies may differ in sidechain conformation, or
in a shift of register between chains while having the same symmetry class, and at the meso
level aggregates with the same symmetry class may have different curvature or aspect ra-
tio. Polymorphism at the level of symmetry class is of particular interest because it can be
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understood physically in terms of the terminus-terminus and other interactions associated
to the peptide chains, which have differing preferences for different symmetries [2].
The mesoscopic shape polymorphism of amyloid aggregates, easily inspected through
a microscope, is very significant in limiting the progress of aggregation towards thermody-
namic equilibrium, creating arrested states with a large proportion of smaller soluble and
neurotoxic aggregates. Twisted and curved aggregates in particular have reduced rates to
assemble hierarchically in comparison to rectangular aggregates, as by definition they must
pay a thermodynamic cost to un-twist in order to create assembly-competent flat planes.
Factors determining twist are complex: from the Ramachandran diagram (Figure 1.3) it is
apparent that AP β strands have slightly less twist than P β , however the relaxed twist of
a β -sheet also depends on the strand length (sheet width): the wider the sheet at a given
pitch, the greater the shear at the sheet edge, therefore wider sheets will tend to have a
longer pitch. Sheet-sheet assembly may take place in multiple geometries, altering the to-
tal curvature of the aggregate in ways which are unpredictable. Parallel in-register β -sheets
have the special property for sheet-sheet assembly that the stacks of identical side-chains
create smooth grooves on the buried surface, allowing sheets to slide past each other and
alter the assembled twist in a labile manner [78]. For the (I/T)(L/F)QINS systems studied
here, assembly at the sheet-sheet interface adds twist with the opposite sign to assembly in
the terminus-terminus direction [75], such that cross-section aspect ratios close to one im-
ply rectangular microcrystal-like aggregates, while very small or very large cross-section
aspect ratios imply bent or twisted aggregates. It has not been shown how general this
effect may be.
Although the hypothesis is extant in the literature that formation of large aggregates is
protective, as these are less toxic than the equivalent number of peptides organised into a
large number of small oligomers [52], it is quite feasible that diversion of oligomers into
bent or twisted nano-fibrils might also be a beneficial strategy in cases that these oligomeric
aggregates are themselves only weakly metastable with limited further assembly, remaining
in balance with a large population of harmless (or even functional) non-amyloid individual
peptides.
1.3 ILQINS, a Lysozyme-Derived Hexapeptide
The ILQINS hexapeptide is a subsequence of Hen’s Egg White Lysozyme, shown empir-
ically to be a significant driver of amyloid formation for the full-length protein [79] and
also for aggregation of digestion fragments [73]. Self-assembly of ILQINS has been inves-
tigated leading to the discovery that pH, concentration, and specific biorelevant mutations
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can select the mesostructure, with the mesostructure then controlling the total amount of ag-
gregation [73, 75]. IFQINS is the human wild-type homologue of ILQINS (with enhanced
in vitro aggregation), and TFQINS is a disease-associated mutation leading to further en-
hanced aggregation in vitro and also to in vivo aggregation associated with disease [80,81]
(see Figure 1.5).
Angstrom-resolution structures have been discovered for IFQINS and TFQINS based
on solid-phase crystallography, with parallel β -strands within β -sheets [82], but solution
assemblies and some precipitated nano- and micro-crystals of these peptides show strong
signals of antiparallel β -sheet. The similar peptides GNNQQNY and NNQQNY (subse-
quences of the Sup35 yeast prion [83]) have been crystallized in parallel β -strands [84]
and also been the subject of simulation or other studies from different groups. The results
of simulations and solid-state NMR show the formation of antiparallel β -strands struc-
tures [12, 85–88] as well as parallel.
Figure 1.5: Three homologous hexapeptides: a ILQINS (from d hen’s egg-white lysozyme
[3WUN]), b IFQINS (from e human lysozyme [1REX]) and c TFQINS (from f mutant
human lysozyme [1IOC]). The hexapeptide sequence is exposed to solvent even in the
folded protein, as it is in the active-site cleft.
The tau protein, related to Parkinson’s disease [89], contains ILQINS homologue se-
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quences VQIVYK and VQIINK. Aggregation inhibitor design targeting these sequences
was successful by taking into account the polymorphic steric zippers for VQIVYK and
VQIINK [90], including structural information from soluble nanocrystal or fibril structures
as well as from microcrystals amenable to solid-phase crystallography. Potential aggrega-
tion inhibitor design for lysozyme-related amyloidosis should therefore also take account of
the polymorphic amyloid structures available. Further disease-related ILQINS homologues
include the recently discovered pathogenic amyloid-former TDP-43 [91], which contains
GNNQNQ and ASQQNQS subsequences.
In this project the thermodynamics and aggregation kinetics of ILQINS and related pep-
tides are studied using molecular simulation methods. The simulation results are analysed
in the context of novel experimental results relating to the bio-relevant solution structures,
as well as with reference to the extant X-ray crystallography results collected from large
solid-phase samples.
1.4 Methods
1.4.1 Classical Molecular Dynamics (MD)
As a tool for microscopic analysis and a complement to conventional experiments, molecu-
lar dynamics (MD) and Monte Carlo (MC) methods can be used in the hope of understand-
ing the properties of the amyloid aggregation process in terms of the structure of molecules
and the microscopic interactions between them [92–95].
The motion of a particle in classical mechanics is specified by the position and velocity
of that particle. If all forces acting on a particle are known, we can specify the state of that
particle at any time by integration of Newton’s equations of motion provided that we know
the initial state of the particle. For many body systems like proteins and peptides, forces
acting on particles can be derived from the negative gradient of the potential energy with
respect to the displacement in a specified direction. We state an analytic expression for the
energy of a system, known as the force field. Force field parameters usually are obtained
from experimental and quantum mechanical studies of small molecules, assuming that such
parameters may be transferred to larger molecules on an additive basis [96]. The force
field function is composed of intermolecular and intramolecular energetic contributions,
including bond stretching, angle bending, bond rotations and non-bonded terms [97]. A
wide variety of force fields for biological molecules are available. Throughout this work
AMBER (Assisted Model Building with Energy Requirement) force field is used.
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Figure 1.6: An overview of the MD procedure, using the AMBER force field and the
Velocity-Verlet integration algorithm.
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The simplest form of the Amber force field uses the following equation [98]:
U(r) = ∑
bonds
kb(r− r0)2
+ ∑
angles
kθ (θ −θ0)2
+ ∑
dihedrals
Vn(1+ cos(nφ − γ))
+
N−1
∑
i=1
N
∑
j=i+1
(
Ai j
R12i j
− Bi j
R6i j
+
qiq j
εRi j
). (1.1)
In Equation 1.1 the individual terms for bond lengths and angles are based on simple
harmonic potentials on the basis of an energetic penalty associated with a deviation from the
equilibrium value. To model the barriers associated with the rotation of bonds a torsional
angle potential function is used. Coulomb and Lennard-Jones (LJ) potentials are also used
to express electrostatic and van der Waals forces, respectively for non-bonding interactions.
In large systems, the solution to Newton’s equation of motion can be gained numerically
by finite difference methods; the continuous time evolution of the system is broken down
in small time steps such that the total force acting on each particle in the system changes
little in a given timestep. An overview of the integration procedure, using the AMBER
force field and the Velocity-Verlet integration algorithm is given in Figure 1.6.
1.4.1.1 Solvent Models
Atomistic MD simulation can be done in explicit or implicit [99] solvent. In explicit-
solvent methods, positions and interactions of both solute and solvent atoms are explicitly
computed. The particle mesh Ewald (PME) is the most commonly used explicit-solvent
method for biomolecular simulations. In this method periodic boundary conditions are im-
posed such that no water ‘surface’ is generated. Short-range electrostatics (on lengthscales
typically 8-12Å, much less than the box size) are treated directly on a pairwise basis, and
long-range interactions are treated by binning the charge distribution onto a grid, such that
it can be subjected to a Fourier transofrm [100] and electrostatic forces can be solved effi-
ciently in the frequency domain. Forces arising from the direct-pairwise and Fourier-mesh
parts of the calculation are mixed using an interpolation function.
In implicit methods, solvent is approximated as a dielectric continuum, so the number
of particles to explicitly keep track of in the system is reduced drastically. An additional
benefit is that the random collisions of solvent molecules to solute can be modelled using
the Langevin equation, either aiming for physical realism or for enhanced sampling by
increasing or decreasing the solvent friction/collision rate [101, 102].
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The generalized Born (GB) solvation model is an implicit solvent model for atomistic
MD simulation. The total solvation free energy of a molecule, ∆Gsolv is decomposed into
the non-electrostatic and electrostatic parts:
∆Gsolv = ∆Gnoel +∆Gel (1.2)
where ∆Gnoel is the free energy of solvating a molecule when the partial charges of every
atom are set to zero and comes from the combined effect of the favorable van der Waals
attraction between the solute and solvent molecules, and the unfavorable cost of breaking
the structure of the solvent around the solute. This is usually taken to be proportional to the
total solvent accessible surface area (SA) of the molecule, with a proportionality constant
derived from experimental solvation energies of small non-polar molecules.
∆Gel is the free energy of first removing all charges in the vacuum, and then adding
them back in the presence of a continuum solvent environment, which is of course more
favourable for the presence of charges: this term dominates the solvation energy in most
cases, certainly for ionic solutes in a high-dielectric medium such as water. The electro-
static energy depends not only on the charge distribution but on the shape of the cavity
created by the exclusion of solvent: a macromolecule such as a protein may have a large
volume at its core which is more akin to vacuum than to solvent in electrostatic terms.
The energy to place an arbitrary charge distribution in an arbitrary solvent cavity is not
analytically available and is traditionally calculated on a grid by numerical solution of the
Poisson-Boltzmann equation. In MD, solution of the Poisson-Boltzmann equation at ev-
ery step is however prohibitively costly, so the GB method is presented as a numerically
cheaper alternative [98, 103].
In this model each atom in a molecule is considered as a sphere of radius Ri with a
charge qi at its center and the interior of the atom is assumed to be filled uniformly with
a material of dielectric constant 1. The molecule is surrounded by a solvent of a high
dielectric ε (80 for water at 300 K) and ∆Gel is approximated by an analytical formula:
∆Gel ≈−12∑i j
qiq j
fGB(ri j,Ri,R j)
(
1− exp[−κ fGB]
ε
)
(1.3)
where ri j is the distance between atoms i and j, the Ri are the so-called “effective Born
radii” and correspond to the self-energy contributions of individual atoms. The atom-pair
contributions are estimated by an analytical certain function fGB that depends upon the
effective Born radii and interatomic distance of the atom pairs [104]. The electrostatic
screening effects of low salt concentration is considered via the Debye-Hückel screening
parameter κ [105].
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fGB is chosen for a specific GB implementation, an example form is [103]:
fGB = [r2i j +RiR j exp(−r2i j/4RiR j)]1/2. (1.4)
For an atom i in a molecule, Ri reflects the degree of its burial inside the molecule: for
an isolated ion, it is equal to its van der Waals radius ρi and assuming κ = 0 for pure water
we obtain the simple form of the solvation energy of a single ion:
∆Gel =− q
2
i
2ρi
(
1− 1
ε
)
. (1.5)
The function fGB interpolates between the limit ri j → 0, when atomic spheres merge into
one, and ri j → ∞, when the ions can be treated as point charges obeying the Coulomb’s
law [98].
1.4.2 Replica Exchange Molecular Dynamics (REMD)
The timescale of protein aggregation is often inaccessible using straightforward MD be-
cause the stable states, defined by the minima in free energy, are usually separated by large
free energy barriers, and straightforward MD simulations frequently become stuck in lo-
cal, metastable minima, and therefore we must use advanced sampling techniques. One
of the successful methods to enhance conformational sampling in molecular simulations is
parallel tempering or REMD [106–110].
In REMD, several replicas of the system are simulated independently and simultane-
ously using classical MD or MC methods at different simulation temperatures [111] or
Hamiltonians [112,113]. At certain intervals, neighboring pairs are exchanged with a spec-
ified transition probability. Usually the temperature is the parameter that varies among the
replicas (T-REMD) and the random walk in temperature allows the trapped conformations
at a low simulation temperature to escape from locally stable states by exchanging with
replicas at higher simulation temperature. This exchange is essentially an MC move in
temperature space, and is accepted with the probability:
Pacc(i←→ j) = min(1,exp(−∆)) (1.6)
∆ = (Uiβ j +U jβi)− (Uiβi+U jβ j) (1.7)
where the inverse temperature β is defined by β = 1/kBT (kB is the Boltzmann constant)
and U represents the potential energy of the system for a given configuration. The above
expression enforces that lower-energy states move to lower-temperature replicas, subject
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to some random mixing. Sampling is enhanced by the communication between high-
temperature replicas, in which free energy barriers are reduced, and low-temperature repli-
cas in which the dynamics are close to gradient descent. It has been recognized that (for
equilibrium classical systems) increased temperature for a given replica is equivalent to
inversely scaling the energy associated with its associated configurations, and that in fact
further more sophisticated modifications to the energy landscape can be made in order to
enhance sampling.
Usually, the replicas are constructed so that one end of the replica set is the ensemble
from which sampling is wanted, and the other end is one where barriers can be crossed more
easily [114]. The resulting sampling will be statistically correct and closer to ergodicity if
the attempts to exchange replicas produce valid ensembles, and the probability of exchange
attempts succeeding is high enough, and the resulting flow of replicas over the ensembles
produces good mixing. The probability of a replica containing a given configuration de-
pends on the potential energy and the temperature (P(x) ∝ e−βU(x)). If two ensembles are
chosen so that their distributions of states have significant overlap, then states have a good
chance to be exchanged between them.
Figure 1.7: In this schematic figure colored arrows represent MD trajectories of replicas
and the black arrows represent attempted swaps between replicas in state space. Question
marks represent Monte Carlo exchange attempts (check marks for successful, cross for
failed).
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The simplest workflow for replica exchange simulations is illustrated in Figure 1.7.
Each replica runs a pre-specified number of MD steps before stopping to attempt exchanges
with one of its nearest neighbours. In general restricting exchange attempts to pairs is not
required and exchanges can involve more than two replicas [98].
1.4.2.1 Hamiltonian Replica Exchange Molecular Dynamics (HREMD)
To investigate the early stage nucleation processes of peptides, biasing potential REMD
(BP-REMD), which is a Hamiltonian REMD (HREMD) method is used. The Hamiltonian
is modified by the addition of a biasing potential for each configuration, imposing a har-
monic force restraining each peptide to an extended reference conformation. The reference
conformation is aligned to each peptide in each MD step so that whole-molecule diffusion
is not altered.
The restraint potential is defined as U(~x,λ ) = 12λ |~x|2, where ~x is the vector of 3N
displacements from the atomic coordinates to the corresponding reference coordinates. We
apply different biasing potential levels in each replica (one replica runs without any biasing
potential as reference replica) and replica exchanges between biasing levels are attempted
at preset intervals, and accepted or rejected according to a Metropolis criterion:
w(Ri←→ R j) = 1 : ∆Ui j ≤ 0,
w(Ri←→ R j) = exp(−β∆Ui j) : ∆Ui j > 0. (1.8)
The energy change for a candidate exchange event is:
∆Ui j =
[
U(λi,~x j)+U(λ j,~xi)
]− [U(λ j,~x j)+U(λi,~xi)] .
At one end of the replica set, one replica runs without any biasing potential as the
reference replica which we want to sample from and at the other end a replica runs with
nearly-rigid extended peptides which have no intra-molecular hydrogen bonds and are thus
highly aggregation prone. The details of specific applications of the method will be dis-
cussed in coming chapters.
1.4.3 Kinetic Monte Carlo (KMC)
Kinetic Monte Carlo (KMC) is a stochastic algorithm used to simulate the time evolu-
tion of dynamic systems from state to state [115]. In this work the event-driven Doob-
Gillespie [116] algorithm is used to investigate the evolution of oligomer formation. This
algorithm is based on the collision of anisotropic bodies within a reaction vessel. It is as-
sumed that all reactions within the Gillespie framework are initiated by at most two bodies
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and reactions involving more than two bodies can be treated as a sequence of binary reac-
tions. The algorithm begins by initializing the number of bodies in the system, reaction rate
constants, and random number generators. The second step is generating random numbers
to determine the next reaction event, and also the wait time to that event. The next step
is updating the time and the counts for each species present, based on the reaction that
occurred. We iterate the procedure by going back to the second step unless the simulation
time has been exceeded.
In order to define reaction rate constants for the KMC algorithm, it is necessary to have
diffusion constants and surface cross-sections for each species (to find collision rates) and
also to define energy barriers for joining following a collision, and also to define energy
barriers for spontaneous fission.
Given that assembly in the hydrogen-bonding axis is considerably stronger than in lat-
eral axes, leading to approximately rod-like aggregates, we employ the formula for dif-
fusion of rod-like bodies given by Ortega and de la Torre [117]. To reduce the number
of distinct species which need to be tracked, we consider only processes for assembly or
splitting of rigid cuboidal assemblies of β -structured peptides, neglecting conformational
changes. The rate for association of two oligomers i and j, drawn respectively from popu-
lations of size Ni and N j, having matching-sized planes in a can be defined via the diffusive
collision rate for anisotropic bodies with surface bLbcLc in a volume V , subject to an expo-
nential barrier of 3kBT representing the entropic cost to remove translational and rotational
degrees of freedom by joining two rigid bodies (a, b, and c are terminus-terminus, sidechain
and hydrogen bonding axes respectively and in this formula they are lattice parameters or
the dimensions of a cuboidal unit cell. La, Lb and Lc are the number of unit cells along a,
b, and c axes respectively).
From this, we are able to define a manageable system of Arrhenius-type rate equations,
suitable for Monte Carlo sampling via the Doob-Gillespie method. Here rate equations are
presented in the form directly useful for simulation, such that the units are s−1:
raa =
2NiN j
V
e−3(Di+D j)
√
2bLbcLc, (1.9)
where Di and D j are the diffusion constants [117].
To calculate a rate for the splitting processes, an energetic scale is necessary. Binding
free energies for interfaces in the a, b and c axes of the simulated microcrystal structures
can be found by calculating the free energy of blocks of peptides separately and joined
together, eg: ∆G◦c = [G◦118− (G◦114+G◦114)], where subscript triplets are the dimensions of
a peptide block or sub-block.
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Figure 1.8: Collision of two species along a axis (a) Two species have matching-sized
planes in a and they join together after collision. (b) Two species have mismatched planes
in a, but they have the same length in b and the collision requires a split in the c axis.
(c) Two species have mismatching-sized planes with different lengths in b and c; collision
requires a split first in b, then another split in c or a split first in c, then another split in b.
Depending on the energy cost of the two reactions of panel (c), only the least expensive is
implemented in order to control the complexity of the simulation.
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The rate for a cuboidal oligomer of size La×Lb×Lc unit cells to split along some plane
perpendicular to the a crystal axis is defined as:
ra =
1
τ0
N(La−1)e
LbLc∆G
◦
a
kBT . (1.10)
Here τ0 is a constant which sets the timescale (taken as the single-peptide diffusion
time [117]) and N is the number present of the given species. The term in the exponential
rapidly becomes large and negative as the area of the interface to be cleaved grows. Rates
for splitting in b or c are available by permuting the indices.
Although simulation of non-cuboidal aggregates was avoided due to the large number of
different species which would then need to be tracked, an approximation to this was made
by allowing non-matching faces to join providing that the non-cuboidal aggregate formed
then splits to form cuboidal products. Figure 1.8 illustrate the three different possibilities
for collision along the a axis.
1.4.4 Molecular Graphics
In this work molecular graphics were prepared using PyMOL [118] and VMD [119]. Sec-
ondary structure types for structure images were assigned using DSSP [3]. We have also
used Inkscape as a free and open-source vector graphics editor to create or edit vector
graphics.
1.5 Overview
In the following chapters the aggregation behaviour of the ILQINS, IFQINS and TFQINS
peptides is quantified and explored. In chapter 2 early-stage competition and coopera-
tion between antiparallel and parallel β -sheet aggregation is identified and examined using
MD and REMD simulations, verified by solution X-ray diffraction (wide-angle X-ray scat-
tering, WAXS). In chapter 3 the presence of mature (late-stage) parallel and antiparallel
structures in solution is shown for the IFQINS peptide by comparing simulation to WAXS,
and mechanisms for concentration-driven competition between large AP and P aggregates
are investigated using MD and KMC, for systems up to millions of coarse-grained peptides
in size. The thesis closes with a discussion chapter 4 in which a synthesis of the results is
presented and implications of the findings are discussed.
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Chapter 2
Antiparallel Strand Alignment as the
Default for Amyloid Oligomers at Early
Times
Amyloid aggregates of a given polypeptide may differ at the atomic or the meso scale. The
most basic difference is between parallel and antiparallel alignment of peptide strands. An-
tiparallel contact between short peptides should be more favourable, due to the proximity
of like charges in parallel alignment, however parallel β -sheet is most often observed via
crystallography of mature aggregates. We combine solution X-ray with molecular dynam-
ics for a set of hexapeptides and find that antiparallel structure dominates for the small
oligomers. Initial formation of sheets is more favourable with antiparallel structure, while
the assembly of two or more existing sheets is more favourable for parallel oligomers. The
present peptide system, similar instances from the literature, and the basic physics of pep-
tide interaction all argue that antiparallel order should be the first formation of amyloid in
most or all amyloid aggregation processes, regardless of the structure of the final mesoscale
aggregate.
2.1 Introduction
Small assemblies of peptides, known as amyloid oligomers, are now verified as toxic
species in multiple neurodegenerative diseases [120]. Oligomers are hard to characterise.
They may be on or off-pathway to the highly stable mature aggregates, and they may have
a variety of structures including parallel or antiparallel peptide strands, in alpha or beta
conformations. Here a computationally generated antiparallel β -sheet conformation is pre-
sented and linked to observed solution X-ray diffraction for the given peptide system, show-
ing that this conformation is dominant in the early phase of aggregation. Thermodynamic
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calculations are used to explain that this early dominance of antiparallel structure should
be common.
Toxic amyloid oligomers play a key role in Alzheimer’s, Parkinson’s and other de-
generative diseases [26, 42–44], while functional amyloids can be applied as unique and
versatile biomaterials in nanotechnology and biomedicine [48–50]. Detailed knowledge
of morphology and structure of amyloids is necessary to fully understand the process of
oligomerization and fibrillization (see Chapter 1). It has been proposed that α-sheet, dif-
fering from β -sheet in that hydrogen bond donors/acceptors are aligned on opposite sides of
the chain, is an important contributor to amyloid-β protein toxicity and early-stage aggre-
gation [121]. High-temperature simulations have also indicated α-sheet in early lysozyme
aggregation [122], with an antiparallel alignment. No α-sheet is observed in the present
work, however the discussion of the importance of antiparallel alignment is to some extent
independent of the α/β question.
Allowed arrangements for pairs of β -sheets (forming ‘steric zippers’ or ‘Q-N zippers’
for the present peptides, where the QxN sequence motif strongly joins pairs of sheets) have
been catalogued as a set of eight ‘symmetry classes’ [2,77,123]. In the introduction chapter,
these symmetries were presented diagramatically (Figure 1.4). Here, Figure 2.1 shows a set
of full (space-filling) crystal lattices generated based on these symmetry classes. A given
symmetry class is compatible with multiple expanded lattices, however solution scattering
suggests unit cell dimensions of aggregates in solution are comparable in the observed
systems to a single steric zipper level (one pair of left hands) [75], supporting the choice of
the simplest, translation-only, lattice.
The I56LQINS61 hexapeptide subsequence of hen’s egg white lysozyme has been shown
to be a significant driver of aggregation in digested or full-length lysozyme [73] and to
have controllable mesostructure-scale polymorphism, with mutations, pH, and initial pep-
tide concentration being used to select in vitro between twisted fibrils (low total aggrega-
tion) and rectangular rod-like fibrils or microcrystals (with higher total aggregation) [75],
even preserving roughly the same atomistic structure and contact topology. Parallel β -
sheet atomistic structures for the ILQINS homologues IFQINS and TFQINS have been
documented using solid-phase X-ray crystallography [82], but solution-phase X-ray scat-
tering from these peptides (and also ILQINS) shows signals which consistent with an-
tiparallel structure in solution, demonstrating atomistic-level polymorphism alongside the
mesostructural polymorphism which has already been discussed.
The argument of this chapter is that antiparallel structure has a significant thermody-
namic advantage relative to parallel structure at the early stages of aggregation. Simula-
tion studies confirm the formation of antiparallel β structures in similar systems such as
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GNNQQNY which have been crystallized in parallel β -sheet [12, 86, 87]. The amyloid
beta [124–126] and the alpha synuclein [127] peptides have been shown to form antipar-
allel (or mixed parallel/antiparallel) oligomers but parallel fibrils, with important implica-
tions for our understanding of neurodegenerative diseases and our strategies for molecular
therapy. Only slightly different fibril morphologies may be associated with substantially
different diagnoses of amyloid disease [128].
Figure 2.1: Amyloid-like lattices based on the eight different symmetry classes, illustrated
with images of left hands. Ra, Rb and Rc show rotations of 180◦ about a, b and c axis.
Classes 1–4 have parallel alignment of β -strands within each β -sheet and classes 5–8 have
antiparallel arrangement of β -strands within their β -sheets. A given peptide sequence may
have metastable aggregates with one or more of these symmetries. A given symmetry
defines only the sheet and steric zipper relationships: multiple space groups not shown,
and also intra-peptide degrees of freedom, may be compatible with a given class.
Here MD simulations of the different symmetry classes of ILQINS aggregates are used
to find the atomistic structure most consistent with the results from solution wide angle
X-ray scattering (WAXS) experiments. The most consistent structure (based on calculated
scattering profiles) has antiparallel β -sheet conformation, contrary to the crystallography
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[82] and to the earlier proposed oligomer/nanocrystal structure [73].
The early stage self-assembly mechanism of ILQINS and its homologues is investi-
gated via Hamiltonian replica exchange molecular dynamics (HREMD) simulations. The
majority of the initial single-sheet aggregates for these systems at room temperature are
observed to be antiparallel. Higher stability of the AP sheets is confirmed relative to single
P β -sheets via un-accelerated MD simulations.
2.2 Results
2.2.1 3D Aggregates of ILQINS in Different Symmetry Classes and
Corresponding WAXS Curves
In order to make a search for the best 3D ILQINS structure in relation to the WAXS data,
one ILQINS model nanocrystallite for each of the eight symmetry classes in Figure 2.1 was
built. All structures were based on the class 1 structure already refined to yield a qualitative
match to scattering data [73]. The new structures in classes 2–8 were subjected to rotations
so as to fulfill the appropriate symmetries and also to minor alterations applied by hand so
as to reduce clashes and generate favourable contacts (see Figure 2.2 for the eight initial
structures).
The calculated scattering changed substantially in the course of the simulation for each
system, even in class 1 which did not show major structural rearrangement to the naked
eye. Among the calculated scattering curves, the structure with symmetry class 5 ended
the simulation in a state overall most consistent with the WAXS experiment (Figure 2.3),
although we should note that the experimental scattering showed a peak at 4.8Å which is a
signature of strands in P β alignment, but is not seen in the AP β structure due the 9.7Å dis-
tance on the c axis between translated equivalent peptides in this geometry. Absence of the
4.8Å reflection in antiparallel amyloid has been confirmed elsewhere via WAXS on AP
α-synuclein fibrils [129].
The inset of Figure 2.3 shows that the Bragg reflections between 20Å and 10Å which
are relevant for unit cell geometry agreed better with the AP structure than with the P
structure. The large peaks at ≈ 20Å and ≈ 10Å are hypothesised to be related to unit
multiples of individual axes (i.e. 100, 200, 010, 020), and are fit by a variety of available
peptide structures as the a and b lattice parameters are roughly constant across structures
(and roughly equal to each other). The two smaller peaks at ≈ 17.5Å and ≈ 13.4Å are
more difficult to assign but have observed to be sensitive to γ indicating that they involve
mixing of two or more non-zero Miller indices, the AP structure class 5 was the only one
to stably capture these two peaks.
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Figure 2.2: Eight initial structures before MD simulations corresponding to the symmetry
classes in Figure 2.1. View is an orthoscopic projection along the c (hydrogen-bonding)
crystal axis, such that the P β structures 1-4 appear to be a 2D wallpaper.
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As both of the Class 1 and Class 5 structures were missing observed peaks, until further
refinement can generate a single structure which reproduces the entire scattering it is as-
sumed that the real solution contains some proportion of both structures. As seen in Figure
2.1, symmetry class 5 has an antiparallel alignment of β -strands within β -sheets. Figure
2.4 shows this structure in detail. The structure arrived at through MD and WAXS does
not have the status of 1Å-resolution crystallography outputs: the limited information from
solution scattering compared to crystallography means that while a match of calculated to
observed scattering is information in favour of a given structure being correct, further com-
putational analysis is needed to provide thermodynamic or kinetic explanations of why it
should be formed.
Figure 2.3: WAXS of ILQINS peptide solution recorded after 24 h of self-assembly
(black), and calculated scattering for the MD snapshot of the 1296-peptide nanocrystal
(6× 12× 18) taken at 10 ns (AP class 5: blue, P class 1: red). The AP lattice parameters
are a = 20.6Å, b = 19.1Å and γ = 82◦, peaks relevant to lattice shape are annotated with
the corresponding Bragg spacing. ILQINS WAXS data supplied by Nicholas P. Reynolds,
Swinburne University of Technology, Australia.
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Figure 2.4: Class 5 AP structure. a Two sequential planes perpendicular to the c axis:
termini are in close contact on the a axis, but not across the steric zipper. b plane perpen-
dicular to the b axis, showing backbones of peptides only. Termini are also in contact along
the c axis and hydrogen bonding is strong. c A molecular dynamics snapshot with semi-
ordered dynamic water molecules shown as orange spheres. The AP lattice parameters are
a = 20.6Å, b = 19.1Å and γ = 82◦.
2.2.2 Energy Decomposition
As an initial test of the idea that AP structures should lead aggregation even though P
structures are more common as insoluble fibrils or crystals, we evaluate binding free energy
gains to join AP and P β -sheets in the c axis and at the steric zipper interface. This is done
by calculating the difference between free energies of joined sheets of peptides (for example
two four-peptide sheets making an eight-peptide sheet) and separated sheets (for example,
the same two four-peptide sheets no longer in contact) e.g.:
∆G◦c = [G118− (G114+G114)]
where integer subscript triplets are the number of peptides in each dimension of a rect-
angular nanocrystal. Reference block free energies Gi jk are calculated as averages over not
less than 50 blocks sampled from the converged part (the tenth nanosecond) of the MD
simulation. After a block is ‘cut’ from the simulation system, its energy is minimised in a
27
continuum solvent [130], so that the final free energy accounts for the electrostatics of sol-
vent exposure, and also contains at least some of the appropriate physical entropy change
from creating an interface, particularly that related to ordering of the solvent.
Table 1 shows the interface formation energy compared for class 1 and class 5 struc-
tures. The larger free energy gain in c to stabilise AP structures is consistent with the
tendency to see single-sheet AP oligomers more than P, while the stronger steric zipper
formation energy (∆G◦zip) for P structures is consistent with eventual dominance of P β
crystals or of P multi-sheet fibrils. Interestingly, the pattern becomes more pronounced in
line with increasing amyloidogenicity [75] of the sequence.
∆G◦c ∆G◦zip
ILQINS P class 1 -28.1(2) -18.6(1)
AP class 5 -28.9(2) -16.3(2)
IFQINS P class 1 -27.1(1) -20.5(1)
AP class 5 -29.3(2) -16.4(3)
TFQINS P class 1 -26.1(1) -21.7(2)
AP class 5 -29.5(2) -13.1(2)
Table 2.1: Standard binding free energy gain to construct a buried interface in the direction
of the beta-sheet hydrogen bonding axis (∆G◦c), and the sidechain steric zipper interface
(∆G◦zip). Units are kcal/mol/peptide buried by the interface. AP is stronger in terms of
sheet elongation but is weaker in zipper stability.
2.2.3 Hamiltonian Replica Exchange Molecular Dynamics (HREMD)
To further investigate the early aggregation process of each system of peptides (ILQINS,
IFQINS and TFQINS), making sure to place no initial assumption on the structure formed,
a Hamiltonian Replica Exchange Molecular Dynamics (HREMD) method was imple-
mented (as described in the introduction 1.4.2 and in the detailed methods below 1.4.2.1).
Each system, each of 64 replicas, contained 64 peptides confined to a spherical volume
of 50Å radius, giving an effective concentration of 0.2 M. With only 64 peptides, the full
aggregation process cannot be investigated however accelerated conformational search via
this method allows the initial steps to be probed. The majority of aggregates formed in
the HREMD calculations had antiparallel alignment of peptide strands, which is consis-
tent with the ∆G calculations and with the terminus-terminus interactions: each uncapped
peptide has an unsatisfied charge at the end, favouring antiparallel alignment.
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Figure 2.5: Number of hydrogen bonds in parallel (red) and antiparallel (blue) bridges
calculated by DSSP [3] analysis for λ = 0 during the simulation time confirms that the
majority of aggregates are forming in antiparallel structures. Thick lines indicate a moving
average over 50 ps
Dominance of the antiparallel aggregates during the simulation time is confirmed by
DSSP [3] analysis for calculating the number of hydrogen bonds in parallel and antiparallel
bridges. Time evolution of the number of H-bonds in P and AP bridges for λ = 0 shows
that the majority of aggregates are in antiparallel structures. Figure 2.5 shows the result of
the analysis for ILQINS system.
Figure 2.6 (a-c) shows the extended reference conformations and Figure 2.6 (d-f) shows
representative single β -sheets for each system taken from the simulations.
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Figure 2.6: (a-c) Extended reference peptides used for HREMD simulations and (d-f)
representative AP single β -sheets formed in these simulations. Sidechain orientation in
the AP sheets initially formed is not regular: the structures (d-f) are mixed between the
intrasheet orderings of classes 5/6 and 7/8.
2.2.4 Classical MD of P and AP Single β -Sheets
We confirm the stability of the antiparallel aggregates by implementing classical molecular
dynamics simulations up to 100 ns in explicit water in 300 K and 1 atm, finding greater con-
figurational stability for the antiparallel rather than parallel single β -sheets. Final structures
from these simulations are shown in Figure 2.7.
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Figure 2.7: Classical MD over 100 ns in explicit water shows that antiparallel single β -
sheets have greater configurational stability than parallel. (a-f): P and AP β structures
consistent with classes 1 or 2 (P) and 5 or 6 (AP), at 100 ns for the three sequences studied.
(g-i): backbone hydrogen bonding declines more rapidly for the P structure in each case.
Thick lines indicate a moving average over a 1 ns window.
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2.3 Discussion
We have analysed the aggregation of a set of amyloidogenic lysozyme-derived peptides.
Calculated scattering profiles show that the symmetry with best agreement to solution
WAXS experiments has antiparallel arrangement of β -strands within the β -sheets, although
indications of parallel β -sheet are also detected, suggesting a mixture of parallel and an-
tiparallel sheet at early stages of aggregation. Accelerated molecular dynamics was used
to search the conformational space for small assemblies (not more than 64 peptides) and
the peptides ILQINS, IFQINS and TFQINS all formed single-sheet antiparallel structures
which were stable on longer timescales (order 100ns) than the equivalent parallel structures.
This observation is consistent with growing evidence from the wider literature that antipar-
allel oligomers precede parallel aggregates for many amyloid systems [12,86,87,124–127].
This observation is physically motivated by the stronger electrostatic interaction of two
extended peptide strands in an antiparallel rather than parallel arrangement, competing
with the countervailing effect (observed for the present systems, and probably very com-
mon) that parallel β -sheet, with its smoother side surface, should have more favourable
sidechain-sidechain stacking in the lateral phase of assembly. The formation of a stable
lateral steric zipper is a crucial stage in amyloid self-assembly, as the doubled thickness
therefore roughly doubles the energetic cost to break the growing aggregate perpendicular
to the c axis, therefore squaring the timescale for which it can be expected to endure in
solution.
This P-follows-AP effect should be quite general to amyloid assembly, particularly for
small peptides where the relative importance of the termini is larger, but evidence also
supports this effect for the much larger Aβ [124–126] and α-synuclein peptides [127]. For
longer peptides, whatever charges or whatever electric dipoles parallel to the strand axis
are present, they cannot prefer a parallel in-register alignment because such a structure
necessarily stacks like charges with like.
Counterexamples to the discussed phenomenon do exist, for example similar accel-
erated MD simulations to those documented here have found that for a pair of human
Islet Amyloid Polypeptide (hIAPP) chains in solution, parallel-β dimerisation is the initial
step [131]: this exception manifests what is a quite common pattern in amyloid forma-
tion, of each chain making a strand-turn-strand ‘horseshoe’ motif, such that the interface
labelled zip in the present work (strong for Pβ ) is formed at the same time as, or before,
the interface labelled c. In the case that axial and zipper ordering are cooperative, or that
zipper ordering precedes axial ordering, the arguments presented here do not apply.
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2.4 Materials and Methods
2.4.1 MD for 3D Aggregates and Scattering Calculations
Each model crystal had 1296 (6× 12× 18) peptides along the a (terminus-terminus) × b
(sidechain) × c (hydrogen bonding) axes. Each structure was immersed in a periodic box
of TIP3P atomistic water [132], then relaxed for 10 ns by MD simulation at 300 K and 1
atm using the ff14SB atomistic forcefield [133] and the pmemd software [134]. Scattering
was calculated by an orientationally averaged Fourier transform of the electron density,
using CRYSOL [135].
2.4.2 Energy Decomposition
The formula applied to estimate a ‘docking’ free energy assumes linearity with the number
of peptides buried by the interface and independence with respect to the block size in the
axis perpendicular to the cut plane. This assumption should hold approximately true for
aggregate sizes above the Bjerrum length. The Bjerrum length is ≈ 7Å when measured
through water, or ≈ 40Å measured through the weaker dielectric of a peptide assembly
(assuming εr = 15 for a small amyloid oligomer). Beyond the use of non-polarisable clas-
sical forcefields, the effective length at which linearity sets in has been found using quan-
tum methods as ≈ 15Å (3 cells) along the c-axis [136], implying an even shorter effective
Bjerrum length than assumed. Cooperativity (non-linearity) arises mainly in the hydrogen
bonding direction, and should be stronger for AP than for P fibrils due to the less pleated
alignment of dipoles, so should magnify rather than diminish the size of the effect in ∆Gc
discussed here.
The a and b axes were calculated by splitting blocks of size 2× 4× 3 peptides down
the middle. The zipper axis was calculated by splitting a geometry 1× 2× 14, the longer
protofibril being chosen to minimise end effects due to an overhang of 2.4Å at the zipper
interface in some candidate structures examined. The c axis was calculated by splitting a
geometry 1×1×14, under the assumption that aggregation in c precedes assembly in other
directions, thus the most relevant regime of ∆Gc is for single-sheet assembly.
2.4.3 Hamiltonian Replica Exchange MD
The HREMD search method [112, 113] was implemented using the NAB (Nucleic Acid
Builder) molecular manipulation language [137]. A generalized Born model [130] was
used to represent the solvent as a continuum. Sixty-four replicas of each system were run
simultaneously using the developed NAB program and the Amber ff14SB forcefield [133].
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The modification to the Hamiltonian for replicas i > 0 was to add a harmonic restraint
driving each peptide towards an extended reference configuration, with the position and
orientation of the reference superimposed on the peptide at each step but the intra-chain
degrees of freedom for the reference held constant. The restraint potential was defined
as U(~x,λ ) = 12λ |~x|2, where ~x is the vector of 3N displacements from the atomic coordi-
nates to the corresponding reference coordinates, λi = 0.032(i/63)2, and the replica index
i runs over [0..63]. The given functional form for λ was verified empirically to provide
good mixing between replicas (see Figure 2.8). Replica exchanges were attempted at 5 ps
intervals.
Figure 2.8: Replica exchange convergence for different sequences; λi = 0.032(i/63)2 was
verified empirically to provide good mixing between replicas (Replica index i runs over
[0..63]). Replica exchanges were attempted at 5 ps intervals. The black trace in each
system shows an arbitrary reference replica.
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2.4.4 Synthesis and Light Scattering
Synthesis was carried out by Wen Li, Kun Liu and Afang Zhang of the University of
Shanghai, China. Light scattering was carried out by Nicholas P Reynolds, Swinburne
University of Technology, Australia.
ILQINS was made by solid phase peptide synthesis from Wangresin with
O-(benzotriazole-1-yl)-1,1,3,3-tetramethylcarbamide tetrafluoroborate (TBTU) as the
coupling reagent and N,N’ diisopropylethylenamine (DiPEA) as the base. 1-
Hydroxybenzotriazole (HOBt) was used to avoid intramolecular cyclization to form dike-
topiperazine. A typical synthetic procedure was: After swelling the resin in DMF
overnight, Fmoc-protected amino acid (4 equiv), TBTU (4 equiv), DiPEA (4 equiv) and
HOBt (4 equiv) in DMF were added and shaken. After coupling for 1 h, the resin was
washed with DMF (4 × 1 min) and DCM (4 × 1 min). Removal of the Fmoc group was
performed with piperidine (15 min). The peptide was cleaved from the resin with HF in the
presence of 10% anisole for 1 h at 0◦C. The crude peptide was precipitated with anhydrous
tert-butylmethyl ether, dissolved in AcOH and lyophilized, which was further purified by
RP-HPLC with gradients of water and acetonitrile.
In order to initiate self-assembly lyophilized ILQINS was mixed with MilliQ water
at 1.5 mM then left to stand for 24 hours. Wide-Angle X-Ray Scattering (WAXS) was
then performed at room temperature using the SAXS/WAXS beamline of the Australian
synchrotron. Samples were loaded into a 96 well plate held on a robotically controlled
x-y stage and transferred to the beamline via a quartz capillary connected to a syringe
pump. A beam of wavelength λ = 1.03320Å (12.0 KeV), cross-section 300 µm x 200
µm and a typical flux of 1.2× 1013 photons per second was used. 2D diffraction images
were recorded on a Pilatus 1M detector. q ranges were between 0.03-1.5Å−1. Spectra
were recorded under flow (0.15 ml min−1) in order to spread the beam damage. A set of
15 spectra was recorded (exposure time = 1 s) and the average spectrum is shown after
background subtraction against MQ water in the same capillary.
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Chapter 3
Kinetic Control of Parallel versus
Antiparallel Amyloid Aggregation via
Mesostructural Polymorphism
By combining atomistic and higher-level modelling with solution X-ray diffraction, self-
assembly pathways are analysed for the IFQINS hexapeptide, a bio-relevant amyloid for-
mer derived from human lysozyme. It is verified that (at least) two metastable polymorphic
structures exist for this system which are substantially different at the atomistic scale, and
the conditions under which they are kinetically accessible are compared.
The higher-level polymorphism for these systems, which manifests as shape differences
between structures instead of or as well as differences in the small-scale contact topology,
is further examined at the nanometre to micrometre scales. Any future design of structure
based inhibitors based on the IFQINS steric zipper should take account of this polymorphic
assembly.
3.1 Introduction
The hydrogen-bonding, hydrophobic and electrostatic interactions which stabilise globular
proteins can also drive the formation of tough multi-chain ‘amyloid’ aggregates which
are often associated in biology with disease [21, 22]. Amyloid formation is implicated
in various pathologies, particularly fatal neurodegenerative diseases such as Alzheimer’s,
Parkinson’s and Huntington’s [26, 42–44]. Beyond the neurodegenerative diseases, certain
inherited amyloidoses may be systemic or else localised in non-brain tissues: Lysozyme
amyloidosis is an example of this class, in which a mutation in the IFQINS subsequence (to
TFQINS) leads to accumulation of amyloid and eventual multiple organ failure [80,81]. A
further relevant sequence variation is ILQINS, the wild type subsequence in Gallus gallus,
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which demonstrates reduced in vitro amyloid formation relative to the human wild type
IFQINS.
In the study of amyloid aggregation it is common to use truncations or subsequences of
longer bio-relevant proteins, in some cases because the protein is indeed truncated in the
biological context but often also for simple convenience. The (I/T)(L/F)QINS peptide sys-
tem has elements of both of these motivations: it was shown using mass spectrometry that
in conditions of warm acid similar to the stomach, full-length lysozyme is hydrolysed into
fragments, and fragments containing (I/T)(L/F)QINS such as Y54GILQINSRWWCND67
dominated the aggregation process [73]. As well as I56T, W64R and D67H are disease-
associated mutations [138], nevertheless in order to develop full understanding and con-
trol of the aggregation process the focus of the present work is on the 6-residue fragment
only. It has been shown that aggregation propensity increases following the sequence
ILQINS→ IFQINS→ T FQINS, and pH7→ pH2 [75]. In the same paper, a compu-
tational prediction that amyloid formation should in some cases decrease with increas-
ing concentration (fewer macro-scale crystals should form, and more monomeric peptide
should remain in solution) was made, and validated experimentally. It should be noted
that this previous paper used different candidate atomistic structures for the hexapeptide
systems but that, as the mutation series only alters sidechains at the unit-cell surface, con-
clusions for self-assembly from that study remain qualitatively unchanged when repeated
using the newer candidate atomistic structures.
Analysis of short peptide steric zippers has in the past led to successful design of in-
hibitors for aggregation of the full-length chain, including aggregation of the Aβ [139] and
tau peptides [140]. Tau includes the VQIVYK and VQIINK homologue hexapeptides of
IFQINS, and effectiveness of inhibitor design was improved by targeting the polymorphic
steric zippers for VQIVYK and VQIINK [90], including structural information from solu-
ble nanocrystal or fibril structures as well as from microcrysytals amenable to solid-phase
crystallography. Effective design of inhibitors for human Lysozyme aggregation should
therefore also benefit from understanding of IFQINS polymorphic steric zippers. The ki-
netic process by which polymorphs compete or cross-seed can potentially be complex. If
amyloid aggregates propagating as prions are a form of highly simplified quasi-lifeform,
then this network of polymorph interactions is the quasi-ecology which determines domi-
nance or extinction of a given fold.
Research into amyloid is not only driven by medical goals, but also seeks to develop
peptide biomaterials [48–50]. One of the motivations to consider amyloid as a biomaterial
is the potential for versatility in material properties driven by polymorphism at the atomistic
or mesoscopic levels: it is common that a given sequence can stably take on a variety of
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morphologies [141] including filaments [71], nanotubes [72] , helical ribbons [73–75],
twisted ribbons [74, 75] and crystals [75, 76] depending on the growth conditions.
Here, solution scattering taken during the aggregation process at high peptide concen-
tration in water is examined showing an aggregated structure for IFQINS that is consistent
with a solid-phase crystal structure previously published (by Sievers et al. [82], pdb code
4R0P [47]), but which is different to the solution scattering previously observed. We show
that the medium-concentration structures previously studied are composed of antiparallel
(AP) β sheet, while the crystal and higher-concentration solution are composed of parallel
(P) β sheet.
The experimental data contrasting these two polymorphic structures which differ in the
symmetry of assembly permits the modelling of the hexapeptide aggregation process and
examination of the physics of selection between polymorphs formed from P and AP β
sheet to be extended beyond the early times that were considered for ILQINS, IFQINS and
TFQINS in the previous chapter (2), up to millions of peptides and timescales in the range
of microseconds to seconds.
3.2 Results
3.2.1 Atomistic Simulations Compared to WAXS
Atomistic models of the IFQINS 4R0P P β crystal structure and a designed AP β structure
were placed in a virtual aqueous environment and allowed to relax for 15 ns (simulation
details in section 3.3), and calculated scattering was compared to WAXS spectra collected
from real solutions with high (5 mM) and low (1.5 mM) concentrations of peptide. The
WAXS for IFQINS at low concentration is very similar to the ILQINS WAXS discussed
in the previous chapter (Figure 2.3) however the high-concentration WAXS is significantly
different.
The lower-concentration experimental scattering agrees quite well with calculations
based on the designed class 5 structure (Figure 3.1 (a,b)), while the X-ray data for a high-
concentration (5 mM) solution of IFQINS after 24 h agrees with scattering calculated based
on the 4R0P deposited crystal structure (Figure 3.1 (c,d)). Despite the differing symmetry
of 4R0P to the AP structure, the overall scattering is not completely dissimilar, however
the 180◦ rotation which accompanies translation along the a-axis in 4R0P leads to fewer
(but not much shifted) peaks in the angular window considered than were observed from
IFQINS aggregated at lower concentrations. Peaks from the 4R0P structure are much
sharper than from the AP structure, both in experiment and simulation, indicating stronger
ordering.
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Figure 3.1: (a) Calculated scattering curve based on computationally derived AP structure,
compared to solution scattering; lattice parameters are a= 20.0 Å, b= 19.1 Å and γ = 83◦.
(b) AP structure, with semi-ordered dynamic water molecules shown as orange spheres.
(c) Calculated scattering based on solid-phase crystal structure after evolution in aqueous
environment for 15 ns. (d) Solid-phase P crystal structure 4R0P of IFQINS (four unit
cells) reported by Sievers; lattice parameters are a = 43.2 Å, b = 19.6 Å and γ = 90◦.
A full translational unit cell is shown as a rectangle in the center. IFQINS WAXS data
supplied by Nicholas P. Reynolds, Swinburne University of Technology, Australia.
3.2.2 Peptide-Level Assembly Thermodynamics
Having arrived at atomistic models for solution nanocrystals, standard free energies are
evaluated to join together the different lattice planes of the nanocrystals under a linear
approximation such that the total energy scales proportionally to the number of peptides
buried by the interface. We find the free energy per peptide for interfaces perpendicular
to the a (terminus-terminus axis), b (sidechain interaction axis) and c (hydrogen bonding
axis) by calculating the difference between free energies of joined blocks of peptides and
separated blocks, for example:
∆G◦a = (G243−2G143)/(4×3),
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where integer subscript triplets i jk are the number of peptides in each dimension of a rect-
angular peptide block or sub-block, and the denominator term is the number of peptides
buried in the reference interface. The free energy to form a steric zipper, creating an inter-
face which cuts through a unit cell of the crystal lattice, was also calculated. This interface,
∆Gzip, is in the plane perpendicular to the b axis, but is stronger than ∆Gb. Where a split-
ting event changes between a single block with even j and two blocks with odd j, ∆Gzip is
relevant rather than ∆Gb.
Reference block free energies Gi jk are calculated as averages over 100 blocks sampled
from the converged part of the MD simulation. After a block is ‘cut’ from the simulation
system, its energy is minimised in a continuum solvent [130], so that the final free energy
accounts for the electrostatics of solvent exposure, and also contains part of the appropriate
physical entropy change from creating an interface, particularly that related to ordering of
the solvent.
Because the 4R0P structure has a herringbone symmetry (group p2 in the ab plane)
rather than pure translational (group p1), the edges of an assembly are jagged with sub-
stantial overhang, and writing the free energy to join two blocks as a straightforward linear
sum is less appropriate than for the class 5 structure (Figure 3.2). As well as these edge
irregularities visible in projections onto the ab plane, adjacent sheets are also stepped by
±0.5c in the vertical c axis, so in general the calculated interface energy based on the ab
plane should be multiplied by nc− 1/2 rather than by nc as is the case for strictly rectan-
gular blocks. Figure 3.2 (f,g) gives definitions for two components of the interface energy,
labelled ε and ε ′, that can be used to compose the binding free energies in the a direction
as:
∆G/(nc−1/2) = (2nb−1)ε/2 (3.1)
and in the b direction as:
∆G/(nc−1/2) = (na−1)ε+naε ′ (3.2)
where na, nb and nc are the numbers of peptides in the a, b and c directions respectively.
That the P lattice free energy is initially gained more slowly than the AP lattice energy
seems like an immediate qualitative explanation for the 4R0P structure to have a higher
nucleation barrier than the AP structure, and therefore for it to form later (or never) under
conditions of lower concentration where nucleation or meta-nucleation is a more significant
limit to the aggregation process, however other differences between the two systems exist
and interact with this phenomenon.
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Figure 3.2: Cartoon showing binding free energies for interfaces in the a (backbone axis),
b (sidechain axis) and c (hydrogen bond axis). (a-d): AP structure has generic in-register
steric zipper 3D assembly. (e-h): Sievers’ structure has herringbone assembly characterised
by two energy terms ε and ε ′. Binding free energies are (f): ∆G = (2nb− 1)ε/2 in the a
direction and (g): ∆G= (na−1)ε+naε ′ in the b direction, where na and nb are the number
of peptides in the a and b directions respectively.
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The standard binding free energies to construct a buried interface associated with each
cleavage plane ∆G◦a, ∆G◦b, ∆G
◦
zip and ∆G◦c are written in TABLE 3.1 in kcal/mol/peptides.
The parameters ε =−18.84, and ε ′ =−5.99 were found in the same way as the others, by
comparing blocks of peptides (see Section 3.3).
IFQINS Structure ∆G◦zip ∆G◦c
designed AP class 5 ∆G◦a =−9.2(1) ∆G◦b =−6.2(1) -16.4(3) -29.3(2)
4R0P P structure ε/2 =−9.4(2) ε ′ =−6.0(1) -25.3(2) -25.3(2)
Table 3.1: Standard binding free energy gain to construct a buried interface between unit
cells in the direction of backbone axis (∆G◦a), sidechain axis (∆G◦b), intra-cell zipper (∆G
◦
zip,
in the plane perpendicular to b), and hydrogen bond axis (∆G◦c). Units are kcal/mol/peptide
buried by the interface. 4R0P structure has herringbone assembly characterised by two
energy terms ε and ε ′ (see Figure 3.2 (f,g)). For the crystal structure, energies are initially
not linear with na, nb and nc however the linear change per increase in dimension at the
limit of large aggregates is shown.
3.2.3 Complex Kinetic Competition
Having identified selection in vitro between two dissimilar structures, the event-driven
Gillespie algorithm (introduced in section 1.4.3) was used to make a kinetic simulation
investigating the competition between the AP and P β -sheet structures over a range of con-
centrations. Figure 3.3 shows the evolving mass of aggregated peptides, broken down by
elongation (Figure 3.3 (a)), then formation of 2D and 3D aggregates (Figure 3.3 (b,c)). A
complex kinetic with two regimes is evident, at low and high concentrations.
At low concentrations (nM-mM) the AP structure elongates noticably faster, as the
weaker ∆G◦c for P β -sheet makes the formation of single-sheet aggregates reversible for
these structures on timescales approximating that of collisions. The lead of AP in form-
ing 1D aggregates translates into formation of 2D and 3D aggregates by hierarchical self-
assembly and the AP system dominates assembly at lower concentrations. The small
amount of P assembly which does take place in this regime shows a stochastic distribu-
tion of wait times, indicating that rare nucleation events are needed for highly stable 3D
P aggregates to form. At high concentrations (mM and up), the gain of the AP system in
forming 1D aggregates is overtaken by the P system in forming 2D aggregates: the stronger
steric zipper and lateral assembly in the P geometry allows it to form 2D structures with
long-term stability while the pool of free monomers is still not fully depleted. At these
higher concentrations the proportion of 1D or higher AP aggregated peptide even takes a
gradual downward trend, as peptides leave the 1D+ AP aggregates and are recruited into
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2D and higher P aggregates. Within the simulation timescale, dominance of P over AP is
never dramatic. The turnover at which the two are roughly equal is located at around 5
mM, the concentration at which a mixed population of fibrils was observed experimentally.
Figure 3.3: Evolution of oligomer formation colored by parallel or antiparallel. Curves i-
viii show concentrations increasing from 5 nM in multiples of 10. Spreads show minimum
and maximum values reached in 10 replicates. Traces are averages over the replicates.
‘Frac. 1D+’ (a) shows peptides incorporated into any aggregate which is identifiably P or
AP, therefore initially describes mostly single-sheet aggregates, for which AP is the most
stable geometry. (b) shows formation of 2D aggregates, where complex kinetics driven by
the availability of 1D aggregates and the stability of 2D+ aggregates begin to take effect.
(c) shows the quite sharp kinetically-driven phase transition between AP dominance and
AP-P coexistence in the final sample.
The mesoscopic shape of the growing aggregates (twist, bend and aspect ratio) has an
important but complex connection to the kinetics, in that bent and twisted aggregates have
reduced possibilities for hierarchical self-assembly without paying an energetic penalty to
un-twist or un-bend (introduced in Section 1.2.3). In the physical system twist and bend
are coupled to cross-section area and aspect ratio, with smaller area implying less cost to
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twist, and an aspect ratio further from one (large Na/Nb or large Nb/Na) implying less
cost to bend [142], although the relationship may be complex. Elastic deformation was
not treated directly in the models presented here, however it is apparent that the turnover
in experimentally observed aggregation at the 1.5 mM to 5 mM range of concentrations
corresponds to an inflection in the aspect ratio behaviour for both P and AP aggregates
(Figure 3.4).
Figure 3.4: Evolution of cross-sectional aspect ratio colored by parallel or antiparallel.
Monomers are counted as both P and AP for purposes of averaging. Spreads show minima
and maxima reached in 10 replicates. Traces are averages over the replicates. Both P and
AP show complex behaviour crossing from µM to mM concentration.
At µM concentrations and below, the AP aspect ratio Na/Nb initially drops very slightly,
driven by steric zipper formation in the plane perpendicular to the b axis (Nb = 2 implies
a steric zipper). The non-zipper hydrophobic b interface is however less stable than the
terminus-terminus a interface (see Table 3.1), so the more stable a interface then takes over
and leads growth, driving formation of large quasi-2D sheet pairs which are likely to be-
come curled ribbons or twisted fibrils in the physical system. Above mM concentrations, a
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and b interfaces are both stable on the timescales of oligomer collision, and the aspect ratios
do not run away to the same extent. Based on aspect ratios, the region of concentrations
from 500µM (Figure 3.4 trace vi) to 5 mM (trace vii) emerges as optimal for formation of
more rectangular, less twisted nanocrystals or thick fibrils in the AP geometry.
The P aspect ratio trace shows that at low concentrations the P system is reliant on for-
mation of a 3D aggregate for stability, so has slow but roughly isotropic growth following
the initial formation of the steric zipper such that Nb = 2. At high concentrations (where
P aggregates are observed empirically), growth in b is enough to stabilise the P system
without much growth in a, so this axis leads the lateral growth but not so much as to cause
dramatic anisotropy.
The crystallisation experiment leading to P β structures used a buffer solution not mod-
elled in simulation, however it may not be a coincidence that it took place via hanging drop
method from an initial concentration of 5 mM [82], the region where P formation is also
strong in the simulation.
3.3 Methods
3.3.1 Molecular Simulation
To relate the crystallography to the nanocrystallites studied via solution X-ray, an atomistic
model nanocrystal of 1296 peptides (roughly cubic, dimension ≈10 nm or 6×6×18 two-
peptide steric zipper) was built following the 4R0P crystal structure, and immersed in a
periodic box of TIP3P atomistic water [132]. The structure was thermalised and allowed to
relax for 15 ns in a simulated aqueous environment using the AMBER molecular dynamics
system [134] and ff14SB forcefield [133] without showing any major reordering. Scattering
was calculated by an orientationally averaged Fourier transform using CRYSOL [135].
Figure 3.1 (c) shows that the calculated scattering curve is compatible with the solution
WAXS spectrum. Four unit cells of the crystal structure are shown in Figure 3.1 (d). The
translational unit cell parameters are a= 43.2 Å, b= 19.6 Å and γ = 90◦, however if lattice
transforms including rotations are permitted, the a cell length becomes 21.6 Å.
3.3.2 Desolvation Energy Calculation
To understand the anisotropic growth kinetics of the competing P and AP structures, free
energies per buried peptide to desolvate a lattice plane ∆G◦a, ∆G◦b, ∆G
◦
c were calculated,
and also ∆G◦zip to bury a steric zipper. Within a linear approximation, the free energy cost
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to break an interface for example in a should be writeable in the form:
∆G = nbnc∆G◦a. (3.3)
This linear approximation should become increasingly valid for larger aggregates, as
edge effects, cooperativity and finite-size thermodynamics become progressively less sig-
nificant. The measured values for ∆G◦a,b,c,zip therefore depend to some extent on the size
of the blocks which are broken or joined in order to evaluate them. In order to have more
accurate free energies close to the decisive region of small initial aggregates, capturing
cooperativity at approximately the right lengthscales 20-40Å, block size combinations for
each interface were chosen as follows, where Gi, j,k is the calculated reference free energy
for a block of size i× j× k:
∆G◦c = (G1,1,10−10G1,1,1)/9 (3.4)
∆G◦zip−P = (G1,2,10−2G1,1,10)/9.5 (3.5)
∆G◦zip−AP = (G1,2,10−2G1,1,10)/10 (3.6)
∆G◦b = (G2,4,3−2G2,2,3)/6 (3.7)
∆G◦a = (G2,4,3−2G1,4,3)/12. (3.8)
Each Gi, j,k is found as an average over 50 blocks cut from the large nanocrystal MD
simulations of P or AP IFQINS structures already used to calculate scattering. Individual
blocks are minimised in a Generalised Born solvent model [130] and the converged ener-
gies averaged. The P zipper energies (∆G◦zip−P) were found by joining two sheets of ten
peptides and then dividing by only 9.5 because of the 0.5c overhang in the c axis between
adjacent sheets defined by the deposited crystal structure. As discussed under the assembly
thermodynamics (Equations (3.1) and (3.2)), the buried area for interfaces is then scaled
up again by nc− 0.5 for the P structure rather than by nc as for the AP structure, thus
recovering the original measured ∆G for the measured interface sizes.
3.3.3 Kinetic Rate Equation Network
The model for self-assembly of the peptides was defined as a system of N rigid bodies
each with six faces labelled a+,a−,b,zip,c+,c−. Collision rates were calculated for the
peptides (and assemblies of them) based on the equations for diffusion coefficients D of
rod-like particles due to Ortega and de la Torre [117]. Any coupling between orientation
and direction of movement was ignored such that collisions were resolved based on the
surface area of the assembly-competent planes, determined from the crystal lattice. In this
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form an example collision rate constant for two rectangular crystallites of shape i, j,k and
u,v,w matching a+ and a− planes such that v = j and w = k is:
ka+a−(u,v,w, i, j,k) = 2e−3 (D(u,v,w)+D(i, j,k))
√
2bc · jk. (3.9)
The barrier term e−3 is assigned based on the loss of translational and rotational degrees
of freedom on joining two peptide blocks, calorimetric studies have found that the true
barrier for small peptides to assemble is indeed of the order 2-5kBT at 300K [143]. For
assembly of larger peptides and proteins an energetic cost to unfold should be added to
the barrier term for monomer collisions, for example a barrier of 10.1kBT (25 kJ/mol) is
quoted for full-length human lysozyme.
Number density of given species in the simulation volume enters the rate equation di-
rectly, with no account made of any spatial correlations in the solution:
ra+a− = ka+a−Ni jkNuvw/V. (3.10)
In the case of homodimerisation, such that i jk = uvw, the symmetry factor Ni jkNuvw is
replaced by Ni jk(Ni jk − 1)/2. In the case that two monomers collide, selection of P or
AP geometry was made with a 50% chance for each. Once a monomer in an assembly
was committed to P or AP, it could return to an uncommitted state only by leaving the
assembly. This model does not allow for heterogenous nucleation of P fibrils from AP,
or for formation of mixed P/AP fibrils: P and AP structures interact only indirectly, by
competing for monomers. Heterogenous nucleation may be added in future iterations of
the research.
To define Arrhenius-like rates for a given aggregate to split, it is necessary to set a
dynamical timescale. For example the rate for aggregates of a given geometry u,v,w to
split on some c plane is set as:
rc(u,v,w) = kc(u,v)Nuvw(w−1) (3.11)
kc(u,v) =
1
τ0
exp [uv∆G◦c/kBT ] (3.12)
where τ0 is chosen as the time for a single peptide to diffuse its own length.
The above system allows a rate equation network for collision of rectangular objects
which have at least one matching face to be constructed, however such a network quickly
and unphysically leads to three populations of aggregates which are extended in each of the
lattice axes, and which have zero rates to combine between populations. In order to control
complexity of the calculation it was not feasible to track the full space of non-rectangular
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aggregates, however these were treated ‘virtually’ by allowing complex collisions includ-
ing a splitting process into the rate, such that objects with only one or zero matching di-
mensions could still collide, and the final state after the reaction would contain again only
rectangular agggregates. Figure 1.8 illustrates the multistep reactions treated. Figure 1.8
(a) corresponds to the single-step collision of Equation (3.10), while for Figure 1.8 (b) we
combine rate constants for joining (ka+a−) and splitting (kc):
ra+a− = τ0kc(2,4)ka+a−(3,4,4,2,4,6)
N3,4,4N2,4,6
V
. (3.13)
The two-to-three body process of Figure 1.8 (c) allows a choice of two pairs of cleavage
planes given a collision surface of two non-matching bodies. To manage the complexity
of the calculation, rates for each choice of planes were calculated, and only the fastest
one retained in the kinetic system. Any process with k < 10−50 was also automatically
discarded from the rate equation system.
The rate equations for single collisions and collision-plus-split are balanced by simple
splitting for single collisions, and by the reverse two body process for the collision-plus-
split, however no three-to-two process was constructed as a simple calculation of likely
rates for this found extremely small values. The two-to-three process also had extremely
low rates, but was retained in order to avoid pathological situations such that a 10×12×102
aggregate could not ever assemble with a 9×10×101 aggregate.
Given the set of rate equations described above (a ‘kinetic master equation’) it should
be possible to make an analytical statement of the non-equilibrium kinetics and the final
equilibrium state of the system [144]. Such analyses typically do not capture stochastic
effects such as nucleation, which are often important for amyloid formation, so instead
the decision was made to sample the rate equation set numerically using the event-driven
Gillespie algorithm [116]. In this method, the rates for all possible forward or backward
processes given the current state of the system are calculated, and a single process to carry
out is then selected randomly with a weight proportional to the rate for that process. The
system is then updated according to the reaction chosen, and the rates re-calculated with
re-use of information from the previous iteration. Rate constants for given reactions are
calculated only once, on the first occasion that given reactants are added to the system,
and then cached so that future rate calculations for that reaction can be made cheaply. For
each simulation system, 6 million peptides were used, and concentration was controlled by
setting the volume V .
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3.3.4 Experimental Methods
Synthesis was carried out by Wen Li, Kun Liu and Afang Zhang of the University of
Shanghai, China. Light scattering was carried out by Nicholas P Reynolds, Swinburne
University of Technology, Australia.
IFQINS was made by solid phase peptide synthesis from Wangresin with
O-(benzotriazole-1-yl)-1,1,3,3-tetramethylcarbamide tetrafluoroborate (TBTU) as the
coupling reagent and N,N’ diisopropylethylenamine (DiPEA) as the base. 1-
Hydroxybenzotriazole (HOBt) was used to avoid intramolecular cyclization to form dike-
topiperazine. A typical synthetic procedure was: After swelling the resin in DMF
overnight, Fmoc-protected amino acid (4 equiv), TBTU (4 equiv), DiPEA (4 equiv) and
HOBt (4 equiv) in DMF were added and shaken. After coupling for 1 h, the resin was
washed with DMF (4 × 1 min) and DCM (4 × 1 min). Removal of the Fmoc group was
performed with piperidine (15 min). The peptide was cleaved from the resin with HF in the
presence of 10% anisole for 1 h at 0◦C. The crude peptide was precipitated with anhydrous
tert-butylmethyl ether, dissolved in AcOH and lyophilized, which was further purified by
RP-HPLC with gradients of water and acetonitrile. For IFQINS the molecular weight of
720.8 Da measured was found to be in good agreement with expected mass of 720.82 Da.
In order to initiate self-assembly lyophilized IFQINS was mixed with MilliQ water at
either 1.5 mM or 5 mM then left to stand for 24 hours, at which point WAXS was used to
characterise the spectra of the assemblies formed.
Experiments were performed at room temperature at the SAXS/WAXS beamline at the
Australian synchrotron. Samples were loaded into a 96 well plate held on a robotically
controlled x-y stage and transferred to the beamline via a quartz capillary connected to a
syringe pump. The experiments used a beam of wavelength of λ = 1.03320Å(12.0 KeV)
with dimensions 300 µm x 200 µm and a typical flux of 1.2×1013 photons per second. 2D
diffraction images were recorded on a Pilatus 1M detector. Experiments were performed
at q ranges between 0.03-1.5Å−1. Spectra were recorded under flow (0.15 ml min−1) in
order to prevent X-ray damage from the beam. Multiples of 15 spectra were recorded for
each time point (exposure time = 1 s) and the averaged spectra are shown after background
subtraction against MQ water in the same capillary.
3.4 Discussion
Here a system with kinetic competition between parallel and antiparallel aggregation is ex-
amined, showing a somewhat counterintuitive pattern whereby the structure with a smaller
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free energy of formation per unit volume (AP) is nonetheless favoured, particularly at low
concentrations, due to having no single high barrier in its metanucleation pathway.
In general, P and AP sheets contrast in that AP systems have stronger axial interactions
in the direction of the β -sheet, while P systems which are antiparallel across the steric
zipper interface can compensate for this by having stronger lateral interactions. In this
specific system the contrast between the P and AP structures is not limited to the β -sheet
symmetry, the two also differ in the relative arrangement of unit cells with the P structure
having a herringbone (or parquet) pattern which buries less surface per lattice plane in the
early stages of lateral growth, even though this growth is ultimately more isotropic and
stronger.
Quasi-2D aggregates, those with a cross-sectional aspect ratio far from 1, are known to
readily form twisted or curled fibrils which are then geometrically hindered from hierar-
chical assembly, leading to slower kinetics, thereby slowing or limiting aggregation [75].
It is now necessary to add a counterexample where the anisotropic type of lateral growth
which leads to fibrils rather than to microcrystals may overall slow the kinetics relative
to 3D growth, but where it is still better for a given polymorph to be growing laterally
than to stay longer at the stage of pure 1D aggregation. This case of early anistotropic
lateral growth leading to eventual dominance is relevant in the context of competition for
monomers against other polymorphs with a longer lag phase.
In this study it was attempted to understand kinetics by quantitatively following the
route structure→ energetics→ kinetics, however it is feasible to build intuition such that
the lattice parameters can directly suggest the conditions which will favour or disfavour a
given aggregation scheme. The picture which now emerges is that strong lateral interactions
are necessary in order to have a fast assembly kinetic, and that lateral interactions must be
of roughly equal strength (suggested by roughly equal-sized lattice planes) in order to have
isotropic aggregates which will ultimately dominate the aggregation process and progress
to form a large amount of precipitate.
Amyloid kinetics are multifaceted. Before the formation of amyloid, oligomeric or
disordered droplet assemblies may or may not form, depending on the sequence and so-
lution, and these may compete with β -structured assemblies, or seed them, or mature into
them [145]. Once β -sheet has been formed, even within a quasi-1D paradigm distinc-
tions can be drawn between elongation following unconnected nucleation events, nucle-
ation plus secondary nucleation, and self-seeding by fragmentation; and these distinctions
have measurable consequences to the kinetic [146]. This quasi-1D approximation should
allow meaningful investigation into the aggregation kinetics in particular at low concen-
trations, where all fibrils must nucleate to a finite thickness in order to be stable, but few
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fibrils will grow to much greater thickness than that required. A 1D picture is also trivially
valid in the case that the chain has steric, electrostatic, or other constraints which prevent
assembly in higher dimensions.
With increasing concentration or increasing interaction strength, reduced free energy
barriers allow lateral assembly either hierarchically (as modelled in the present work) or
via secondary nucleation of new beta sheets at the surface of existing sheets [147]. The
resulting intermediate-dimensionality extended structures, between pseudo-1D fibrils and
pseudo-infinite 3D crystals, may be present in various competing polymorphic shapes. This
study has presented and discussed an example in which two of these mesopolymorphic
structures compete with each other, preventing or indefinitely delaying dominance of the
more thermodynamically stable polymorph in a manner which is compatible with the Ost-
wald step rule.
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Chapter 4
Discussion
Atomistic computer models give structural information at the most detailed level possible,
subject to systematic error but with arbitrary spatial precision. Here, simulation meth-
ods were used to understand the formation of amyloid oligomers and mesostructures. Al-
though this project was specifically focused on the ILQINS hexapeptide and its homologues
IFQINS and TFQINS, the computational methods developed can be exploited to study and
describe many similar biological systems.
The results of the project reveal that at early times in the aggregation process, antiparal-
lel structure dominates among the small oligomers formed. In a specfic system (IFQINS),
simulation methods were used to confirm and elucidate kinetic competition in vitro between
structures with parallel and antiparallel alignment of β -strands.
4.1 Antiparallel Structure Dominates Initially
Comparing the calculated scattering curves of 3D aggregates of ILQINS in different sym-
metry classes with the experimental data shows that the symmetry with best agreement to
solution WAXS experiments has antiparallel arrangement of β -strands within the β -sheets,
although indications of parallel β -sheet are also detected, suggesting a mixture of P and AP
sheet at early stages of aggregation. The single-sheet aggregates resulting from HREMD
simulations spontaneously formed antiparallel structures, which were verified to be stable
on timescales longer than the equivalent parallel structures. These results and reasoning
imply that antiparallel strand alignment is the default for amyloid oligomers at early stage
self-assembly of peptides (Chapter 2).
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4.2 Kinetic Competition Between P and AP Aggregation
Comparing the calculated scattering curves of two different 3D structures of IFQINS ver-
ifies that (at least) two metastable polymorphic structures exist for this system which are
substantially different at the atomistic scale. One of the computational structures derived,
with antiparallel arrangement of β -strands within the β -sheets, was consistent with scat-
tering observed from multiple peptides at low and high concentrations whereas the crystal-
lographic structure 4R0P, with parallel arrangement of β -strands within the β -sheets, has
only so far been verified to form starting from high initial peptide concentration. A kinetic
simulation investigating the competition between the AP and P β -sheet structures over a
range of concentrations was presented in Chapter 3.
4.3 Context in Aggregation Mechanisms and Kinetics
It has recently been remarked in reference to nucleation in a system of metal atoms that ‘all
nuclei that adopt an equilibrium shape are alike; every non-equilibrium-structured nucleus
has its own shape’ [148]. If the nucleation of metals is complex and various, amyloid
formation is many times more so. Amyloid nucleation is certainly not a quasi-equilibrium
process: rearrangement times for the internal degrees of freedom of nuclei are comparable
to or longer than the timescales for addition or removal of monomers to the nuclei.
Amyloid is the endpoint of a complex kinetic network containing several reaction steps
of nucleation and growth [149]. Kinetics and the mechanisms of aggregation are very
important in determining the properties and functions of the final products and from an
overview of the various biophysical studies, a broad overall mechanism for the formation
of amyloids can be proposed [24, 150]. The variety of amyloid reactions can then be ex-
pressed as a choice of pathways through this complex network of states, with the probability
for each choice determined by sequence, concentration and other experimental conditions
(Figure 4.1).
As a default for in-vitro and in-silico systems, amyloid aggregation is activated ini-
tially by primary nucleation, which generates the first pre-critical nuclei from dissolved
monomers. The nuclei can be parallel or antiparallel dimers or various other small solu-
ble species collectively known as oligomers. As nuclei grow they typically become more
ordered, either in a continuous way with collectivity strengthening intramolecular intera-
tions, or through a sharply defined ‘ripening’ from liquid-like micelles or other droplets
into solid-like sheets.
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Figure 4.1: Schematic overview of peptide aggregation pathways. Vesicle, Micelle and
Bilayer images CC licenced by Mariana Ruiz Villarreal. β -barrel structure is 4RLC.
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Some oligomeric species represent kinetic dead-ends, but others can grow into larger
species like ordered sheets with strong translational symmetry, from sheets into protofibrils,
and eventually into mature aggregates. The ‘maturity’ of an aggregate is relative: twisted
fibrils and helical ribbons may represent the end state or may eventually convert to crys-
tals. It was observed that fibril-to-crystal conversion occurs within single aggregates via
untwisting of twisted fibrils possessing saddle-like curvature and cross-sectional aspect ra-
tios approaching unity [75]. Changing sequence, pH or concentration can shift the growth
towards larger aspect ratio species assembling into stable helical ribbons possessing mean-
curvature [75]. Although in most amyloid systems fibril growth is thermodynamically
downhill after the initial barrier, elongation reactions can in principle be reversible.
Amyloid formation may include secondary nucleation processes which involve typi-
cally the fragmentation of fibrils induced by either thermal energy or mechanical forces
[151, 152]. These breakage events multiply the number of fibrils and increase the concen-
tration of reactive fibril ends that can recruit monomers and elongate. Secondary nucleation
process may also involve the generation of new oligomers catalyzed by the presence of the
surfaces of existing fibrils [41, 153].
Secondary nucleation of monomers on fibrils surface involves at least three molecular
events: arrival of peptide at the fibrils surface, formation of product and release. Secondary
nucleation is unsaturated at low monomer concentration, and the observed overall aggrega-
tion profiles are strongly dependent on monomer concentration. The process may saturate
at high monomer (substrate) concentration and the observed overall aggregation profiles
show little dependence on monomer concentration [41]. Such saturation is observed for
Aβ upon reduced electrostatic repulsion due to salt screening, pH variation, or mutation,
implying that secondary nucleation is not a single-step reaction [154–157].
The overview of the peptide aggregation landscape in Figure 4.1 includes pathways
for which novel physics which was introduced and quantified in this work: the route from
monomers to parallel/antiparallel β -sheet was found to be more rapid for antiparallel β -
sheet, while the routes from sheet to ribbons/fibrils/crystals were found to be faster from
parallel β -sheet. It was found for the specific competing P/AP polymorphs of the IFQINS
system that the AP polymorph had a (concentration-dependent) faster path to helical rib-
bons, with an inflection in the amount of expected ribbon at the mM-µM concentration
range.
That there is no route from helical ribbons to fibrils or crystals is an important assump-
tion made in this work, which gives ribbons the status of kinetic traps, ultimately limiting
the total aggregation in the system. Whether this limitation of the aggregation is harmful
or beneficial in a medical context is beyond the present study to specify.
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4.4 Outlook
Clinical trials have been underway for various aggregation inhibitors over the previous
years (an example review is [158]), although as a rare genetic disease lysozyme amyloidosis
is not much studied in a clinical context, better understanding of the amyloid structural
biology and kinetics should inform further work on this topic. Close homologues of the
sequences studied are important for various other more widespread (and probably also
more complex) diseases; it is possible that the present work can inform research into these
major public health problems.
The developed computational methods should be beneficially applicable to a wide range
of peptide systems, but are still definitely susceptible to improvement. The choice of
Hamiltonian modification for the replica exchange method was made ad hoc and other
augmented Hamiltonians might be more effective. The kinetic simulation included only a
subset of the entities in Figure 4.1, and considerably more sophistication could be added to
this treatment without a major conceptual revision, such as some method of treating mixed
parallel and antiparallel oligomers, or even the full range of symmetries. The kinetic as-
sembly algorithm treats all oligomers as cuboidal and this is justified also by the lack of
terracing in the experimentally observed mature structures (see Fig. 1 in [75]). The lack
of treatment of terracing is related to a lack of treatment of secondary nucleation between
heterogenous or similar fibrils and future work can potentially include such phenomena.
For example, the current algorithm could be developed by considering the attachment of
the building blocks (one peptide or two-peptide steric zipper) to the preformed crystal sur-
face. In the next steps, blocks attaching to the surface will be more stable if they adsorb to
the surface in sites adjacent to the preadsorbed blocks because in this case they will form
more than one bound (one with surface and other(s) with the adjacent block(s)). So another
layer will be growing on the crystal surface. Next layers can be formed and grow on the
previously formed and growing layers as the same way.
A comprehensive multiscale modelling tool for intelligent control of peptide structure
formation would be a wonderful thing, but would probably require major conceptual re-
vision. The combination of molecular mechanics and the Gillespie algorithm has been
surprisingly effective but the assumption of perfect mixing in the Gillespie method seems
increasingly suspect as aggregates increase in size, and although incorporation of elastic
degrees of freedom into the growing aggregates in the Gillespie algorithm can be con-
ceived, in practice the calculations needed to parameterise such a treatment are expensive
and complicated. With imagination, perhaps something which moves past these limitations
can be assembled with only a few more years of work.
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